Clinical Trials Logo

Clinical Trial Summary

Hypnosis has already shown to decrease pain and anxiety in different surgical specialities. Nevertheless, its input has never been studied in cardiology. This research is a prospective, monocentric, controlled and randomized study.

Patients over 18 years old and hospitalized for atrial flutter ablation may be included and randomized into one of the arms: placebo or hypnosis.

Global pain will be assessed by a visual analogue pain scale. Anxiety, morphine consumption, and patient sedation will also be assessed.

The aim of this study is to improve the care given to patient undergoing atrial flutter ablation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03250871
Study type Interventional
Source Poitiers University Hospital
Contact
Status Completed
Phase N/A
Start date October 2, 2017
Completion date September 26, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06359678 - The Northstar Trial N/A